• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Hospital Account Specialist-Cardiovascular

anonymous

Guest
Suddenly, I see several postings for this job description. Please provide insight on the job/pod or matrix team? - expansion? back fill for resignations? Base salary and compensation information will be appreciated.
 








Hospital reps are flying out the door in cv because the drug isn't an inpatient drug. Due to a big realignment, several reps got let go and the rest got territories jacked. Many wondering if they'll still be around come Jan-March.
 
















True, but many patients are started in Hospitals and need to continued on HF meds after discharge. So having the hospitalists, case managers, and discharge planners all set up to to this is a pretty big deal if you want to grow this drug.

The problem w/ this statement is that the Hospital has to have Entresto on their formulary system which in most cases it is not. There are not many Hospitals supporting a $500.00 a month drug. The only MDs using Entresto are the Cards that are being paid by NVS to speak and then the start is in the Card. office not the Hospital or the PA/NP Hospitalist working for the Card. Either way it's the Card.

Don't fool yourself people, ill-advised statements, like the poster above, probably by an ABL is doing no one any good. There are no case managers suggesting Entresto nor discharge planners either. The above poster is just using a lot of fancy positions words that they know darn well is not, nor will not be able to endorse Entresto inside the hospital.
 




The problem w/ this statement is that the Hospital has to have Entresto on their formulary system which in most cases it is not. There are not many Hospitals supporting a $500.00 a month drug. The only MDs using Entresto are the Cards that are being paid by NVS to speak and then the start is in the Card. office not the Hospital or the PA/NP Hospitalist working for the Card. Either way it's the Card.

Don't fool yourself people, ill-advised statements, like the poster above, probably by an ABL is doing no one any good. There are no case managers suggesting Entresto nor discharge planners either. The above poster is just using a lot of fancy positions words that they know darn well is not, nor will not be able to endorse Entresto inside the hospital.

100% correct and sadly it shows that are senior leadership knows nothing about hospital sales
 




The problem w/ this statement is that the Hospital has to have Entresto on their formulary system which in most cases it is not. There are not many Hospitals supporting a $500.00 a month drug. The only MDs using Entresto are the Cards that are being paid by NVS to speak and then the start is in the Card. office not the Hospital or the PA/NP Hospitalist working for the Card. Either way it's the Card.

Don't fool yourself people, ill-advised statements, like the poster above, probably by an ABL is doing no one any good. There are no case managers suggesting Entresto nor discharge planners either. The above poster is just using a lot of fancy positions words that they know darn well is not, nor will not be able to endorse Entresto inside the hospital.


Nah, just a rep that knows what is going on and the drug costs 500 a month for a month supply, patients may take a few does in-house before discharge or started at discharge. Thank you very much, but I am making my Entresto goals because i have a clue about what I am doing.
 




The problem w/ this statement is that the Hospital has to have Entresto on their formulary system which in most cases it is not. There are not many Hospitals supporting a $500.00 a month drug. The only MDs using Entresto are the Cards that are being paid by NVS to speak and then the start is in the Card. office not the Hospital or the PA/NP Hospitalist working for the Card. Either way it's the Card.

Don't fool yourself people, ill-advised statements, like the poster above, probably by an ABL is doing no one any good. There are no case managers suggesting Entresto nor discharge planners either. The above poster is just using a lot of fancy positions words that they know darn well is not, nor will not be able to endorse Entresto inside the hospital.

Wow, complete stupidity! Entresto, nationally is on over 90% of the hospital's formulary. Also, it doesn't cost the hospital 500 a month. If you understood the hospital sales process, which you clearly don't, you would understand that patients are given 6 pills (at most) during their length of stay. This equates to $40 for the stay. Entresto doesn't even make a hospital pharmacy top 50 spend. So, cost is a non issue. Cards are the biggest users yes, but the mid-level providers, and in some cases, the hospitalists are instrumental in identifying and starting patients on after a consult.

The reality is, the TOC process and having providers do something different in the world of heart failure during a hospitalization is the challenge. It is called medical inertia and apathy.

More importantly, the company has decided to have way too many people calling on many of the same customers with absolutely nothing new to talk about. Couple that with 2 day ride alongs every 3-4 weeks, and excessive micromanagement. This dynamic exists for both the hospital and CV salesforce's. HAS' try to have their providers initiate inpatient, while the CV side chases signatures and fakes calls... it's all nonsense
 




Wow, complete stupidity! Entresto, nationally is on over 90% of the hospital's formulary. Also, it doesn't cost the hospital 500 a month. If you understood the hospital sales process, which you clearly don't, you would understand that patients are given 6 pills (at most) during their length of stay. This equates to $40 for the stay. Entresto doesn't even make a hospital pharmacy top 50 spend. So, cost is a non issue. Cards are the biggest users yes, but the mid-level providers, and in some cases, the hospitalists are instrumental in identifying and starting patients on after a consult.

The reality is, the TOC process and having providers do something different in the world of heart failure during a hospitalization is the challenge. It is called medical inertia and apathy.

More importantly, the company has decided to have way too many people calling on many of the same customers with absolutely nothing new to talk about. Couple that with 2 day ride alongs every 3-4 weeks, and excessive micromanagement. This dynamic exists for both the hospital and CV salesforce's. HAS' try to have their providers initiate inpatient, while the CV side chases signatures and fakes calls... it's all nonsense

Opsie Daisy.....Care to rethink your babble????? https://www.lumere.com/blog/ask-procured-health-should-hospitals-add-entresto-to-formulary/
 








No, I don't care to rethink my babble... What else do you ask Lumere about?? That is the independent opinion of a blog.. haha!! Good grief, any other credible sources you'd care to sport?? Again, reality is, it is on over 90% of hospital's formulary. Your blog didn't address that fact... wink wink..

Hey Wink Wink, did you even look to see what Lumere does or who they work w/?
 




Wondering why these positions are posted if you just went thru a realignment? I would think Novartis would fill with internal candidates
The hospital reps weren't making crap for bonuses, their goals were unrealisti. These folks were vested in their 401Ks after 3 years with Novartis after that was up many made a mass exiting. Amgen picked up a lot of great reps and offering them much higher base salary, and attainable bonuses.
 




Should be pretty easy to figure out. What does the data say? How much is coming out of the hospital? Also, how many hospital s does each rep have ? One hospital can be worked in 1 day. So what do they do the other 4 days?
 












The time period of this study includes the time period almost entirely when Entresto was not in the guidelines and insurance coverage was non existent to poor. More recent data would be different.
 








That's hilarious! Novartis doesn't fill with internal candidates - that's only one of the reasons that Novartis has a horrible company culture. They don't care that all the good reps have left or are leaving. The CV division is a horrible place to be!